Team Telomere Inc logo

Team Telomere Shark Tank Grant

Team Telomere Inc

Funding Amount

Not stated

Deadline

Deadline not published

Grant Type

Foundation

Deadline history & next window

Cycle
Annual
Tracked since
April 2026

Source: the cycle recorded on this listing. Confirm dates with the funder.

Overview

Funds bold and innovative ideas with the potential to move the field of Telomere Biology Disorders forward. Seeks creative, patient-focused proposals that take risks, explore new territory, and address gaps in diagnosis, care, or treatment of TBDs.

Focus Areas:

  • Bold and innovative research ideas
  • Patient-focused proposals
  • Novel approaches to diagnosis
  • New care strategies
  • Treatment advancements
  • Addresses gaps in understanding and management of TBDs

Year Launched: 2025

What Team Telomere Inc actually gave

Source: IRS Form 990, 2025

Grants in 2025
5
Total given
$239K
Median grant
$25K
Range
$5,000–$169K
  • By dollars: Massachusetts 71%, Pennsylvania 15%, Texas 13%. Top recipient cities: Boston, MA; Houston, TX; Philadelphia, PA.
  • 0% of grants with a stated purpose were for general or operating support.

Example grants

  • Boston Childrens Hospital · Boston, MA

    Research

    $169K

  • Baylor College of Medicine · Houston, TX

    Research

    $30K

  • University of Pennsylvania · Philadelphia, PA

    Research

    $25K

  • Uplifting Athletes · Doylestown, PA

    Research

    $10K

  • The Trustees of Columbia University · New York, NY

    Research

    $5,000

IRS Form 990, 2025. Amounts as reported by the funder. Full 990 history →

Focus Areas & Funding Uses

Fields of Work

  • Science research
  • Foundation

Categories

Browse similar grants by category

Related Grants

Open grants from this funder and similar programs

Your AI grants department

Ready to apply for Team Telomere Shark Tank Grant?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found Team Telomere Shark Tank Grant. Now let's win it.

Start writing